Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01982123 · ClinicalTrials.gov registry record · NA
SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy
A NA study of Malignant Neoplasm and Lung Carcinoma, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 2
- Study locations
NCT01982123: Completed NA study of Malignant Neoplasm and Lung Carcinoma, sponsored by University of Washington.
NCT01982123 is a NA study of Malignant Neoplasm and Lung Carcinoma that has completed, run by University of Washington. The registered enrollment target is 12 participants, below the 513-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01982123, a NA study of Malignant Neoplasm and Lung Carcinoma, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 2
- Study locations
Study Summary
This pilot clinical trial studies single photon emission computed tomography (SPECT)/computed tomography (CT) in measuring lung function in patients with cancer undergoing radiation therapy. Diagnostic procedures that measure lung function may help doctors find healthy lung tissue and allow them to plan better treatment.
Primary Outcome
Perfusion and ventilation on SPECT/CT pre-radiation, mid-radiation, and post-radiation were compared to assess stability over time. Coefficient of determination (R²) was generated based on voxel-based comparisons between scans (R²=1 means perfect reproducibility in perfusion and ventilation between scans), based on regions outside the radiation field.
Conditions Studied
Interventions
- PROCEDURE Single Photon Emission Computed Tomography
- DIAGNOSTIC_TEST SPECT/CT
- RADIATION Technetium Tc-99m Albumin Aggregated
- DRUG Technetium Tc-99m DTPA
Study Locations (2)
Washington
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium - Seattle
- ProCure Proton Therapy Center-Seattle - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-01-17 |
| Est. Completion | 2017-09-13 |
| Phase | NA |
What the finished NCT01982123 record still lists
NCT01982123 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 513-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Malignant Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Single Photon Emission Computed Tomography is the first listed.
NCT01982123 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01982123 about?
NCT01982123 is a clinical study titled "SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy". This pilot clinical trial studies single photon emission computed tomography (SPECT)/computed tomography (CT) in measuring lung function in patients with cancer undergoing radiation therapy. Diagnostic procedures that measure lung function may help doctors find healthy lung tissue and allow them to ...
What is the current status of trial NCT01982123?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2014-01-17. Estimated completion is 2017-09-13.
What conditions does trial NCT01982123 study?
This clinical trial studies the following conditions: Malignant Neoplasm, Lung Carcinoma.
What interventions are being tested in trial NCT01982123?
The interventions under investigation include: Single Photon Emission Computed Tomography (PROCEDURE), SPECT/CT (DIAGNOSTIC_TEST), Technetium Tc-99m Albumin Aggregated (RADIATION), Technetium Tc-99m DTPA (DRUG).
Who is sponsoring clinical trial NCT01982123?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01982123 being conducted?
This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01982123's enrollment target sits among peer trials
12 56th of 59 higher than 3 of 59 other Malignant Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
RECRUITING · NA
-
Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
RECRUITING · NA
-
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
RECRUITING · NA
-
Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer
RECRUITING · NA
-
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant
RECRUITING · NA
-
Reproductive Health Program in Patients With Cancer
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI